[1] Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother, 2009; 21 Suppl 1, 3−4.
[2] Sudhaharan S, Kanne P, Vemu L, et al. Bacteriological profile of intra-abdominal infections in a tertiary care hospital. Iran J Microbiol, 2018; 10, 208−14.
[3] Armstrong C. Updated guideline on diagnosis and treatment of intra-abdominal infections. Am Fam Physician, 2010; 82, 694−709.
[4] Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections in a worldwide context: an observational prospective study (CIAOW Study). World J Emerg Surg, 2013; 8, 1.
[5] Humphries R, Bobenchik AM, Hindler JA, et al. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st Edition. J Clin Microbiol, 2021; 59, e0021321.
[6] Zhang S, Huang WX. Epidemiological study of community- and hospital-acquired intraabdominal infections. Chin J Traumatol, 2015; 18, 84−9.
[7] De Waele J, Lipman J, Sakr Y, et al. Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect Dis, 2014; 14, 420.
[8] Shree N, Arora BS, Mohil RS, et al. Bacterial profile and patterns of antimicrobial drug resistance in intra-abdominal infections: current experience in a teaching hospital. Indian J Pathol Microbiol, 2013; 56, 388−92.
[9] Zhang SY, Ren LL, Li YS, et al. Bacteriology and drug susceptibility analysis of pus from patients with severe intra-abdominal infection induced by abdominal trauma. Exp Ther Med, 2014; 7, 1427−31.
[10] Zhao CJ, Chen HB, Wang H, et al. Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013. Natl Med J China, 2015; 95, 1739−46. (In Chinese)
[11] Zhang JG, Zhao CJ, Chen HB, et al. A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) 2007-2016. Infect Drug Resist, 2018; 11, 2311−9.
[12] Babinchak T, Badal R, Hoban D, et al. Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010. Diagn Microbiol Infect Dis, 2013; 76, 379−81.
[13] Sartelli M, Coccolini F, Kluger Y, et al. WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections. World J Emerg Surg, 2021; 16, 49.
[14] Zhang H, Yang QW, Liao K, et al. Antimicrobial Susceptibilities of aerobic and facultative gram-negative bacilli from intra-abdominal infections in patients from seven regions in China in 2012 and 2013. Antimicrob Agents Chemother, 2016; 60, 245−51.
[15] Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect, 2016; 22 Suppl 1, S9-14.
[16] Hu FP, Zhu DM, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis, 2018; 67, S128−34.
[17] Zahar JR, Lesprit P. Management of multidrug resistant bacterial endemic. Med Mal Infect, 2014; 44, 405−11.
[18] Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother, 2009; 53, 1983−6.
[19] Lima AL, Oliveira PR, Paula AP. Acinetobacter infection. N Engl J Med, 2008; 358, 2846.